| Interval Training in Young Healthy Individuals (NCT00733941) | Norwegian University of Science and Technology | 2008-09-01 |
| GSK1349572 Drug Interaction With Tenofovir (NCT00726336) | GlaxoSmithKline | 2008-08-01 |
| The Influence of Amitriptyline on Learning in a Visual Discrimination Task (NCT01566825) | Dieter Kunz, MD | 2008-08-01 |
| Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism (NCT00999271) | Hvidovre University Hospital | 2008-08-01 |
| Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model (NCT00743704) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2008-08-01 |
| Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257 (NCT00722501) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-08-01 |
| An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers. (NCT00699608) | GlaxoSmithKline | 2008-07-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K (NCT01387087) | Astellas Pharma Inc | 2008-07-01 |
| A Trial to Determine How Long Insulin and FDKP (the Molecule That Forms Technosphere Particles) Stays in the Lungs of Healthy Individuals After Inhalation of Technosphere® Insulin (TI) Powder Using Bronchoalveolar Lavage (BAL) (NCT00757367) | Mannkind Corporation | 2008-07-01 |
| Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects (NCT00705042) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-07-01 |
| Development of a Metabolic Assessment Tool for Chronic Kidney Disease (NCT01838239) | University of California, Davis | 2008-06-01 |
| Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy (NCT00754091) | Procter and Gamble | 2008-06-01 |
| A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers (NCT00674050) | Mannkind Corporation | 2008-05-01 |
| Mass Balance Study of ASP1941 (NCT01302132) | Astellas Pharma Inc | 2008-05-01 |
| A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib (NCT00513253) | GlaxoSmithKline | 2008-04-01 |
| Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects (NCT00672399) | AstraZeneca | 2008-04-01 |
| A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration. (NCT00721344) | Mannkind Corporation | 2008-04-01 |
| GW823296 Repeat Dose Study In Healthy Male And Female Subjects (NCT00675116) | GlaxoSmithKline | 2008-04-01 |
| Non-invasive Measurement of Hemoglobin in Retinal Arteries (NCT01025011) | Triemli Hospital | 2008-03-01 |
| Combination of Probiotic and Calcium in Healthy Adults (NCT01033461) | University of Jena | 2008-03-01 |
| Measurement of MRP2 Function Using Urinary Coproporphyrins (NCT00746044) | University Hospital, Tours | 2008-02-01 |
| Bioequivalence Study of SB797620 in Healthy Japanese Volunteers (NCT00549263) | GlaxoSmithKline | 2008-02-01 |
| GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study (NCT00631592) | ViiV Healthcare | 2008-02-01 |
| Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects (NCT01365624) | American Regent, Inc. | 2008-02-01 |
| Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults (NCT00671814) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-01-06 |
| Endothelial Dysfunction Induced by Postprandial Lipemia (NCT00660491) | Norwegian University of Science and Technology | 2008-01-01 |
| Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers (NCT00785460) | Ruhr University of Bochum | 2008-01-01 |
| Effects of Increased Muscle Mass on Resting Metabolic Rate (NCT01325038) | University Hospital, Linkoeping | 2008-01-01 |
| A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State (NCT01121926) | Labopharm Inc. | 2008-01-01 |
| The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects (NCT00767598) | Inje University | 2007-12-01 |
| To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects (NCT01424332) | Astellas Pharma Inc | 2007-12-01 |
| A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers (NCT00608699) | GlaxoSmithKline | 2007-12-01 |
| In Situ Caries of Fluoride Toothpastes (NCT00708123) | GlaxoSmithKline | 2007-11-01 |
| Dose Response and Efficacy of GW842166 in Pain (NCT00554762) | GlaxoSmithKline | 2007-11-01 |
| A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects (NCT00540501) | GlaxoSmithKline | 2007-10-01 |
| A Second Study to Determine the Effect of GSK256073A on HVTs (NCT00551694) | GlaxoSmithKline | 2007-10-01 |
| A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers (NCT00539136) | GlaxoSmithKline | 2007-10-01 |
| GSK706769 A First Time in Human Study For Males and Females (NCT00539201) | GlaxoSmithKline | 2007-09-01 |
| The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes (NCT00678522) | Regional Hospital Holstebro | 2007-09-01 |
| Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects. (NCT00536497) | GlaxoSmithKline | 2007-09-01 |
| A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers (NCT01765868) | Portola Pharmaceuticals | 2007-09-01 |
| Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males (NCT00540553) | GlaxoSmithKline | 2007-08-01 |
| hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects (NCT00742235) | Massachusetts General Hospital | 2007-07-01 |
| Exploring the Effects of Diazepam and Lorazepam (NCT00696033) | University Hospital, Strasbourg, France | 2007-07-01 |
| Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. (NCT00474864) | GlaxoSmithKline | 2007-07-01 |
| GSK372475 Bioequivalence Study (NCT00488098) | GlaxoSmithKline | 2007-07-01 |
| Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine (NCT00562237) | Solvay Pharmaceuticals | 2007-07-01 |
| Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate (NCT03642873) | Reckitt Benckiser LLC | 2007-05-05 |
| Eltrombopag Taste Testing in Healthy Adult Volunteers (NCT00487968) | GlaxoSmithKline | 2007-05-01 |
| Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males. (NCT00468806) | GlaxoSmithKline | 2007-04-01 |
| A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects. (NCT00424697) | GlaxoSmithKline | 2007-03-01 |
| Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects (NCT01365611) | Egalet Ltd | 2007-02-01 |
| STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study (NCT01181505) | Inje University | 2007-01-01 |
| A Study of GSK1325760A in Healthy Japanese Subjects (NCT00424034) | GlaxoSmithKline | 2007-01-01 |
| The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake (NCT00678184) | Regional Hospital Holstebro | 2007-01-01 |
| An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam. (NCT00423761) | GlaxoSmithKline | 2006-12-01 |
| A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects (NCT00443170) | GlaxoSmithKline | 2006-11-01 |
| To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug (NCT00436228) | GlaxoSmithKline | 2006-11-01 |
| Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males (NCT00435695) | GlaxoSmithKline | 2006-11-01 |
| A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers. (NCT00429728) | GlaxoSmithKline | 2006-11-01 |
| Study Evaluation LXR-623 in Healthy Adults (NCT00379860) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-10-01 |
| Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults. (NCT00383916) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-10-01 |
| Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers (NCT01033799) | Danone Global Research & Innovation Center | 2006-10-01 |
| Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone (NCT00376324) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650 (NCT00364039) | Avigen | 2006-08-01 |
| Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development (NCT00401232) | Pfizer | 2006-08-01 |
| Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate (NCT00369304) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects (NCT02796118) | Astellas Pharma Inc | 2006-07-01 |
| A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers (NCT01476800) | Astellas Pharma Inc | 2006-07-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy (NCT00380900) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body (NCT01655056) | Astellas Pharma Europe B.V. | 2006-06-01 |
| Glucagon Modulation of Ghrelin Secretion (NCT00929812) | Charite University, Berlin, Germany | 2006-06-01 |
| The Effects of Coffee (NCT00336271) | American University | 2006-04-01 |
| A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions (NCT00297843) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2006-03-01 |
| 4 mg Nicotine Polacrilex Gum and Swedish Portion Snus (NCT01182129) | Contract Research Organization el AB | 2006-03-01 |
| Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol (NCT00678834) | Chandan K Sen | 2006-03-01 |
| A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation (NCT01478529) | Astellas Pharma Inc | 2006-02-01 |
| Efferocytosis and Genomic Polymorphism in Autoimmune Diseases (NCT00364728) | National Taiwan University Hospital | 2006-01-01 |
| Oral Ghrelin Agonist in Healthy Subjects (NCT00377377) | University Hospital, Basel, Switzerland | 2005-11-01 |
| Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone. (NCT00154037) | Technische Universität Dresden | 2005-10-01 |
| Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects (NCT00368238) | Yale University | 2005-10-01 |
| Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone. (NCT00154011) | Technische Universität Dresden | 2005-09-01 |
| Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 mg Nicotinic Acid as Tablets in Healthy Subjects (NCT01258491) | Heidelberg University | 2005-05-01 |
| To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females (NCT01478503) | Astellas Pharma Inc | 2005-05-01 |
| Pharmacokinetics of Ghrelin (NCT00116025) | University of Aarhus | 2005-03-01 |
| Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study. (NCT00481182) | GlaxoSmithKline | 2005-02-01 |
| A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions (NCT01646294) | Astellas Pharma Europe B.V. | 2005-01-01 |
| GLP-1 - Regulatory Mechanism of Postprandial Glycemia (NCT00980083) | Ludwig-Maximilians - University of Munich | 2004-10-01 |
| Study Evaluating Pneumococcal Vaccine in Healthy Infants (NCT00205803) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-09-01 |
| mRNA Expression in Lymphocytes of Glaucoma Patients (NCT00327509) | University Hospital, Basel, Switzerland | 2004-01-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects (NCT02944474) | Idorsia Pharmaceuticals Ltd. | 2003-12-01 |
| Characterization of Local Vascular Effects of LNMMA (NCT00180063) | Technische Universität Dresden | 2003-10-01 |
| A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions (NCT00834288) | Labopharm Inc. | 2003-06-01 |
| Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin. (NCT00154024) | Technische Universität Dresden | 2003-03-01 |
| Ghrelin Decreases Insulin Sensitivity (NCT00512525) | University of Aarhus | 2003-01-01 |
| Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects (NCT00690170) | Yale University | 2002-12-01 |
| A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects (NCT02944487) | Idorsia Pharmaceuticals Ltd. | 2002-10-01 |
| Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device (NCT01356212) | Egalet Ltd | 2002-09-01 |
| To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol (NCT01478490) | Astellas Pharma Inc | 2002-09-01 |
| Comparability DE vs CD-CHO1 (NCT00277199) | Bristol-Myers Squibb | 2002-09-01 |